US Drug Maker Hit With Three Billion Dollar Fine

Jul 02, 2012

By Scott Walker

Share on

A major US drug manufacturer has been hit with the highest penalty ever paid to the US government in a case of health fraud.

Glaxosmithkline will have to pay three billion dollars and plead guilty for promoting two of its anti-depression drugs …. Paxil and Wellbutrin … for other uses that were not authorized by the government. It’s a practice known as off-label marketing.

The company also failed to report side effects of its diabetes drug, Avandia.

A spokesman says the government wanted to hit Glaxosmithkline with as heavy a payment as possible because drug companies tend to view fines as the cost of doing business.

Zoomer Kids
You Don't Have To Be A Zoomer To Love Zoomer Radio.
Check out what the Kids have to say!
Join Our Fan Club
Coverage Area
Downtown Toronto
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
ZoomerRadio Logo

Recently Played: